COST-EFFECTIVENESS OF ALGINIC ACID IN COMBINATION WITH PROTON PUMP INHIBITOR FOR THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE IN SYSTEMIC SCLEROSIS PATIENTS

被引:0
|
作者
Foocharoen, C. [1 ]
Kingkaew, P. [2 ]
Teerawattananon, Y. [2 ]
Mahakkanukrauh, A. [1 ]
Suwannaroj, S. [1 ]
Manasirisuk, W. [1 ]
Chaiyarit, J. [3 ]
Sangchan, A. [4 ]
机构
[1] Khon Kaen Univ, Dept Med, Fac Med, Khon Kaen, Thailand
[2] Minist Publ Hlth, Dept Hlth, Hlth Intervent & Technol Assessment Program HITAP, Nonthaburi, Thailand
[3] Khon Kaen Univ, Dept Stat, Fac Sci, Khon Kaen, Thailand
[4] Khon Kaen Univ, Srinagarind Hosp, Special Med Ctr, Fac Med, Khon Kaen, Thailand
关键词
Gastrointestinal tract; Systemic sclerosis;
D O I
10.1136/annrheumdis-2023-eular.495
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0923
引用
收藏
页码:1678 / 1678
页数:1
相关论文
共 50 条
  • [1] Cost-effectiveness of alginic acid in combination with proton pump inhibitor for the treatment of gastroesophageal reflux disease in systemic sclerosis patients
    Foocharoen, Chingching
    Kingkaew, Pritaporn
    Teerawattananon, Yot
    Mahakkanukrauh, Ajanee
    Suwannaroj, Siraphop
    Manasirisuk, Witsarut
    Chaiyarit, Jitjira
    Sangchan, Apichat
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (10) : 2037 - 2046
  • [2] Factors Contributing Cost-Effectiveness for Treatment of Gastroesophageal Reflux Disease (GERD) and the Selection of Proton Pump Inhibitor (PPI) in Japan
    Saitoh, Toshihito
    Tonomura, Hideo
    Otsuka, Kuniaki
    GASTROENTEROLOGY, 2009, 136 (05) : A488 - A488
  • [3] COST-EFFECTIVENESS ANALYSIS OF PROTON PUMP INHIBITORS FOR TREATMENT OF SEVERE GASTROESOPHAGEAL REFLUX DISEASE IN MEXICO
    Pozo Urquizo, L.
    Latapi, E.
    Soto Molina, H.
    Polanco, A. C.
    VALUE IN HEALTH, 2012, 15 (04) : A139 - A139
  • [4] Combination Treatment With Proton Pump Inhibitor Plus Prokinetic for Gastroesophageal Reflux Disease
    Tariq, Muhammad Ali
    Ahmed, Bilal
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2022, 28 (01) : 164 - 164
  • [5] The Cost Effectiveness of Adjunctive Treatments for Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease
    Rosas, Ulysses S.
    Almario, Christopher V.
    Yu, Kyung-Sang
    Spiegel, Brennan M. R.
    CLINICAL DRUG INVESTIGATION, 2024, 44 (09) : 703 - 714
  • [6] Treatment of proton pump inhibitor-resistant patients with gastroesophageal reflux disease
    Yoshikazu Kinoshita
    Hideaki Kazumori
    Shunji Ishihara
    Journal of Gastroenterology, 2006, 41 : 286 - 287
  • [7] Treatment of proton pump inhibitor-resistant patients with gastroesophageal reflux disease
    Kinoshita, Y
    Kazumori, H
    Ishihara, S
    JOURNAL OF GASTROENTEROLOGY, 2006, 41 (03) : 286 - 287
  • [8] Outcomes in patients with nonerosive reflux disease treated with a proton pump inhibitor and alginic acid +/- glycyrrhetinic acid and anthocyanosides
    Di Pierro, Francesco
    Gatti, Mario
    Rapacioli, Giuliana
    Ivaldi, Leandro
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2013, 6 : 27 - 33
  • [9] Prevalence and predictors of proton pump inhibitor partial response in gastroesophageal reflux disease in systemic sclerosis: a prospective study
    Chingching Foocharoen
    Kitti Chunlertrith
    Pisaln Mairiang
    Ajanee Mahakkanukrauh
    Siraphop Suwannaroj
    Suwassa Namvijit
    Orathai Wantha
    Ratanavadee Nanagara
    Scientific Reports, 10
  • [10] TRANSORAL INCISIONLESS FUNDOPLICATION IS COST EFFECTIVE COMPARED TO LAPAROSCOPIC NISSEN FUNDOPLICATION AND PROTON PUMP INHIBITOR STRATEGIES FOR THE TREATMENT OF REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE: A COST-EFFECTIVENESS ANALYSIS
    McCarty, Thomas R.
    Jirapinyo, Pichamol
    James, Lyndon
    Chan, Walter W.
    Thompson, Christopher C.
    GASTROINTESTINAL ENDOSCOPY, 2020, 91 (06) : AB154 - AB154